Search results for #AntiAmyloid
Worried about the @US_FDA delaying its #donanemab decision? Don’t, neurologists say: bit.ly/3VWWXfC #NeuroTwitter #Alzheimers #AntiAmyloid
The #FDA decision to hold an Advisory Committee for #donanemab is likely due in part to the #AntiAmyloid drug's unique trial design. Our CSO, @a_hfillit, discusses the #biomarker-powered trial that used #tau staging and stopping rules in @biospace: bit.ly/4acT0HE
#neurodegenerativedisease #antiamyloid #antimicrobial #antibiofilmprotein LL-37 and CsgC exemplify the crosstalk between anti-amyloid, antimicrobial, and anti-biofilm protein activities journals.lww.com/nrronline/full… @UABBarcelona
Most popular read this week: Over 50 percent of commercial payers aren’t covering #lecanemab. Here’s why: bit.ly/3Nt8Lky #NeuroTwitter #dementia #AntiAmyloid #Alzheimers @AANmember
.@CMSGov has removed its limitations on #PETscans—a change that will be important for monitoring patients treated with #AntiAmyloid drugs for #Alzheimers disease: bit.ly/3uOYuJm #NeuroTwitter @AANmember @UCSFmac @UNCneurology @WisconsinADRC @BruceHCohen @jasonkarlawish
Coverage denials for the #AntiAmyloid therapy #lecanemab have varied among commercial payers—as have the requirements to be eligible for reimbursement: bit.ly/47JKGOz #NeuroTwitter @AANmember @jchambers241 @Duke_Neurology @OHSUNews @PittADRC
While #AntiAmyloid, gantenerumab, didn't meet its endpoints, the data was published in @NEJM with an editorial on lessons learned in the trial. Our CSO, @a_hfillit, shared his thoughts with @FierceBiotech, emphasizing early treatment & #CombinationTherapy: bit.ly/3GiqIhL
For #WorldAlzheimersDay, we highlight this paper by Wojtunik-Kulesza K et al. in @IJMS_MDPI that provides a comprehensive discussion of #antiamyloid antibody therapeutic strategies for treating #Alzheimer's disease. Recommended by Ilya Bezprozvanny. connect.h1.co/article/742566…
Are your patients asking about #donanemab? Here’s why some clinicians are cautiously optimistic about the new #Alzheimers drug: bit.ly/44IV8np #NeuroTwitter #dementia #AntiAmyloid #aging @AANmember
Lecanemab is one of the new antiamyloid monoclonal antibodies, which target amyloid-β protein - a key player in the development of AD. But it's important to note these treatments come with unique risks and treatment burdens. #NewTreatment #Antiamyloid
📣 Join us at #ESMINT2023 @esmintsociety on Sept. 4, 11:58 CEST, as Prof. Gilles Allali takes the stage. You won't miss this chance to hear our esteemed Editor-in-Chief of #NeurodegenerDis share insights on #antiamyloid drugs for #Alzheimersdisease. ℹ️ ow.ly/HtYA50PAN9t
Safe and effective ways to introduce #antiamyloid medications for #AD depends on comprehensive care infrastructure from screening to administration, according to a speaker at @TheNewANA1. bit.ly/3Lmd3t2
#Dementia #Alzheimers #hope Another hope for people suffering with #MCI Mild Cogntitive Impairment & Mild #Alzheimers #Dementia #Donanemab #antiamyloid therapy @hyderabaddoctor @ompsychiatrist @DrDebanjanBane1 @JAMAPsych Ref: doi:10.1001/jama.2023.13239 1/3
Accelerated #brain atropy with anti #amyloid drugs which may affect long term brain health. bit.ly/41oP02r #nursepractitioner #mentalhealth #psychiatry #medicine #primarycare #mhchat #mh #dementia #memory #cognition #mh #confusion #Alzheimers #antiamyloid
#Altzheimers #Lecanemab v. #Biologics. The newest treatment approved to fight Alzheimer's is an #antiamyloid -works directly on the possible cause, instead of just symptoms -target the protein fragments that build up in brain & form plaques, a defining feature of the disease.
#Altzheimers #Lecanemab v. #Biologics. The newest treatment approved to fight Alzheimer's is an #antiamyloid -works directly on the possible cause, instead of just symptoms -target the protein fragments that build up in brain & form plaques, a defining feature of the disease.
Rogers commented on the nature of #antiamyloid drugs and their effect on the disease. However, there is another way of approaching AD: disease management. Read more here: biospace.com/article/some-e… #Alzheimers #MemoriesAreWorthFightingFor